wtaf average people are using chatgpt to make custom mRNA vaccines
An Australian entrepreneur bypassed traditional labs, using AI to create a personalized canine cancer treatment.
In a striking case of AI-augmented citizen science, Australian tech entrepreneur Dr. Daniel Krizner turned to OpenAI's ChatGPT to design a personalized mRNA vaccine for his 13-year-old dog, Bingo, who was diagnosed with terminal hemangiosarcoma. Faced with a poor prognosis and no viable commercial treatments, Krizner, who holds a PhD in biotechnology, used the large language model as a research assistant. He prompted ChatGPT to analyze scientific literature, identify relevant genetic sequences from the canine genome and similar cancers, and help design a vaccine blueprint targeting the tumor's specific markers.
Krizner then took the AI-generated design to a synthesis lab in China, which produced the physical mRNA vaccine for approximately $7,000. After administering the vaccine to Bingo, he reported a significant reduction in the dog's tumor size and extended survival. While not a controlled clinical trial and with outcomes shared anecdotally, the story has gone viral as a provocative example of AI's democratizing potential in biotech. It demonstrates how tools like ChatGPT can help bridge knowledge gaps, allowing determined individuals outside traditional pharmaceutical pipelines to participate in complex, life-sciences problem-solving.
The incident raises immediate questions about safety, regulatory oversight, and the ethical boundaries of DIY biohacking. However, it also points to a future where AI agents could significantly lower the barrier to entry for personalized medicine, enabling faster, more tailored therapeutic design. This story is less about creating a proven cure and more about showcasing a new, AI-powered workflow for biomedical innovation that challenges the slow, expensive status quo of drug development.
- Tech CEO Dr. Daniel Krizner used OpenAI's ChatGPT to research and design a custom mRNA vaccine blueprint for his dog's terminal cancer.
- The AI-assisted design was synthesized by a lab in China for ~$7,000, leading to reported tumor reduction and extended survival for the dog.
- The case highlights AI's potential to democratize complex biotech research, accelerating personalized treatment design outside traditional pharmaceutical pipelines.
Why It Matters
This demonstrates AI's power to accelerate and personalize medicine, potentially disrupting the slow, multi-billion dollar drug development industry.